Saturday 17 October 2026
Export VECT’s income statement to Excel — free account
VectivBio Holding AG
VECT Healthcare Biotechnology
VectivBio Holding AG’s revenue for fiscal 2022 (year ended December 2022) was $27.3 million.
Follow VECT
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Dec '21 | Jun '22 | Dec '22 | |
|---|---|---|---|
Net Income |
(209.75) | (222.50) | (256.29) |
Depreciation & Amortization |
— | — | 0.93 |
Other operating activities |
— | — | 60.14 |
Operating Cash Flow |
— | — | (176.37) |
Capital expenditures |
— | — | (0.24) |
Other investing activities |
— | — | (5.39) |
Investing cash flow |
— | — | (6.83) |
Repayment/Issuance of Debt (Net) |
— | — | 12.52 |
Other financial activities |
— | — | (32.38) |
Financing cash flow |
— | — | 422.26 |
Exchange Rate Adjustment |
— | — | 1.99 |
Change in Cash |
— | — | 241.04 |
Beginning Cash |
— | — | 265.40 |
Ending Cash |
— | — | 506.44 |
Dividends Paid (Common) |
— | — | 0.00 |
Assets Liabilities Change (Total) |
— | — | 26.47 |
Issuance/Purchase of Shares |
— | — | 442.54 |
In millions of $ except per-share values · columns are period end dates